PSAT1 is a known target in NFE2L2/KEAP1 mutant lung cancer cell lines and was elevated in lung cancer and PDX tissues compared to adjacent lung tissues, suggesting serine biosynthesis could be an attractive target in SCC30,43. Here, NFE2L2 is linked to lung carcinoma.